{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:05:06Z","timestamp":1790636706165,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsmedizin Greifswald"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Chronic kidney disease (CKD) is characterized by a gradual and irreversible decline in renal function. Arginine derivatives like symmetric dimethylarginine (SDMA) and asymmetric dimethylarginine (ADMA) have been associated with the progression of renal disease in cross-sectional studies. This study aimed to investigate the longitudinal associations between arginine derivatives and renal function over time in a population-based cohort. Data were derived from the Study of Health in Pomerania-START (SHIP-START-0, n\u2009=\u20093100, mean age 49\u00a0years, women 51.3%). The 5-year follow-up included 2174 and the 10-year follow-up 1657 individuals. At baseline, serum concentrations of Arg, ADMA, SDMA and homoarginine were measured using liquid chromatography\u2013tandem mass spectrometry, while renal parameters (creatinine and cystatin C) were quantified at baseline, 5- and 10-year follow-up. Three different statistical analyses (linear regression, logistic regression, analyses of covariance (ANCOVA)), were performed to investigate the longitudinal associations between baseline levels of Arg, ADMA, SMDA and homoarginine as exposure and renal function parameters as outcome. The results showed a significantly inverse longitudinal association between SDMA and renal function. Specifically, a one \u03bcmol\/l greater SDMA was related to an odds ratio of 1.77 (95% confidence interval (CI) 1.41; 2.21) at 5-year follow-up and 1.43 (95% CI 1.11; 1.84) at 10-year follow-up for kidney dysfunction defined as estimated glomerular filtration rate less than 60\u00a0ml\/min\/1.73\u00a0m<jats:sup>2<\/jats:sup>. These findings suggest that SDMA might predict future deterioration of renal function. This supports previous findings which suggested that SDMA may be a biomarker for renal function.<\/jats:p>","DOI":"10.1038\/s41598-025-14842-y","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T07:51:23Z","timestamp":1755676283000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Symmetric dimethylarginine as a biomarker of renal impairment after a decade of follow-up"],"prefix":"10.1038","volume":"15","author":[{"given":"Hendrik","family":"Meyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"D\u00f6rr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Hannemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edzard","family":"Schwedhelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"B\u00f6ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till","family":"Ittermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nele","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bahls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"issue":"8","key":"14842_CR1","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.3390\/jcm9082359","volume":"9","author":"S Roumeliotis","year":"2020","unstructured":"Roumeliotis, S., Mallamaci, F. & Zoccali, C. Endothelial dysfunction in chronic kidney disease, from biology to clinical outcomes: A 2020 update. J. Clin. Med. 9(8), 2359 (2020).","journal-title":"J. Clin. Med."},{"issue":"2","key":"14842_CR2","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1161\/CIRCRESAHA.116.306531","volume":"119","author":"PM Vanhoutte","year":"2016","unstructured":"Vanhoutte, P. M. et al. Thirty years of saying no. Circ. Res. 119(2), 375\u2013396 (2016).","journal-title":"Circ. Res."},{"issue":"1","key":"14842_CR3","first-page":"147","volume":"2010","author":"RC Jin","year":"2010","unstructured":"Jin, R. C. & Loscalzo, J. Vascular nitric oxide: Formation and function. J. Blood Med. 2010(1), 147\u2013162 (2010).","journal-title":"J. Blood Med."},{"issue":"6174","key":"14842_CR4","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/333664a0","volume":"333","author":"RM Palmer","year":"1988","unstructured":"Palmer, R. M., Ashton, D. S. & Moncada, S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333(6174), 664\u2013666 (1988).","journal-title":"Nature"},{"issue":"21","key":"14842_CR5","doi-asserted-by":"publisher","first-page":"5751","DOI":"10.1016\/S0021-9258(18)62716-4","volume":"245","author":"Y Kakimoto","year":"1970","unstructured":"Kakimoto, Y. & Akazawa, S. Isolation and identification of N-G,N-G- and N-G,N\u2019-G-dimethyl-arginine, N-epsilon-mono-, di-, and trimethyllysine, and glucosylgalactosyl- and galactosyl-delta-hydroxylysine from human urine. J. Biol. Chem. 245(21), 5751\u20135758 (1970).","journal-title":"J. Biol. Chem."},{"key":"14842_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/0471140856.tx1716s58","volume":"58","author":"MS Augustine","year":"2013","unstructured":"Augustine, M. S. & Rogers, L. K. Measurement of arginine metabolites: Regulators of nitric oxide metabolism. Curr. Protoc. Toxicol. 58, 17 (2013).","journal-title":"Curr. Protoc. Toxicol."},{"issue":"9","key":"14842_CR7","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1093\/ndt\/gfl292","volume":"21","author":"JT Kielstein","year":"2006","unstructured":"Kielstein, J. T. et al. Symmetric dimethylarginine (SDMA) as endogenous marker of renal function\u2014A meta-analysis. Nephrol. Dial. Transpl. 21(9), 2446\u20132451 (2006).","journal-title":"Nephrol. Dial. Transpl."},{"issue":"15","key":"14842_CR8","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.clinbiochem.2016.07.009","volume":"49","author":"JM El-Khoury","year":"2016","unstructured":"El-Khoury, J. M. et al. Comparison of symmetric dimethylarginine with creatinine, cystatin C and their eGFR equations as markers of kidney function. Clin. Biochem. 49(15), 1140\u20131143 (2016).","journal-title":"Clin. Biochem."},{"issue":"4","key":"14842_CR9","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1681\/ASN.2005101119","volume":"17","author":"SM Bode-B\u00f6ger","year":"2006","unstructured":"Bode-B\u00f6ger, S. M. et al. Symmetrical dimethylarginine: A new combined parameter for renal function and extent of coronary artery disease. J. Am. Soc. Nephrol. 17(4), 1128\u20131134 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"9","key":"14842_CR10","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s00726-015-2055-5","volume":"47","author":"D Tsikas","year":"2015","unstructured":"Tsikas, D. & Wu, G. Homoarginine, arginine, and relatives: Analysis, metabolism, transport, physiology, and pathology. Amino Acids 47(9), 1697\u20131702 (2015).","journal-title":"Amino Acids"},{"issue":"3","key":"14842_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/biom8030063","volume":"8","author":"M Bahls","year":"2018","unstructured":"Bahls, M. et al. Low-circulating homoarginine is associated with dilatation and decreased function of the left ventricle in the general population. Biomolecules 8(3), 63 (2018).","journal-title":"Biomolecules"},{"issue":"9","key":"14842_CR12","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1007\/s00726-015-1993-2","volume":"47","author":"S Pilz","year":"2015","unstructured":"Pilz, S. et al. Homoarginine in the renal and cardiovascular systems. Amino Acids 47(9), 1703\u20131713 (2015).","journal-title":"Amino Acids"},{"issue":"3","key":"14842_CR13","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/BF01324255","volume":"46","author":"U John","year":"2001","unstructured":"John, U. et al. Study of Health In Pomerania (SHIP): A health examination survey in an east German region: objectives and design. Soz. Praventivmed. 46(3), 186\u2013194 (2001).","journal-title":"Soz. Praventivmed."},{"issue":"6","key":"14842_CR14","doi-asserted-by":"publisher","first-page":"e372","DOI":"10.1093\/ije\/dyac034","volume":"51","author":"H Volzke","year":"2022","unstructured":"Volzke, H. et al. Cohort profile update: The study of health in Pomerania (SHIP). Int. J. Epidemiol. 51(6), e372\u2013e383 (2022).","journal-title":"Int. J. Epidemiol."},{"issue":"6","key":"14842_CR15","doi-asserted-by":"publisher","first-page":"e0131293","DOI":"10.1371\/journal.pone.0131293","volume":"10","author":"M Bahls","year":"2015","unstructured":"Bahls, M. et al. L-arginine and SDMA serum concentrations are associated with subclinical atherosclerosis in the study of health in Pomerania (SHIP). PLoS ONE 10(6), e0131293 (2015).","journal-title":"PLoS ONE"},{"issue":"7","key":"14842_CR16","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1080\/00365519950185229","volume":"59","author":"C Ric\u00f3s","year":"1999","unstructured":"Ric\u00f3s, C. et al. Current databases on biological variation: Pros, cons and progress. Scand. J. Clin. Lab. Invest. 59(7), 491\u2013500 (1999).","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"14842_CR17","unstructured":"Aarsand, A. K., F.-C.P., Webster, C., Coskun, A., Gonzales-Lao, E., Diaz-Garzon, J., Jonker, N., Simon, M., Braga, F., Perich, C., Boned, B., Marques-Garcia, F.., Carobene, A., Aslan, B., Sezer, E., Bartlett, W. A. & Sandberg, S. The EFLM Biological Variation Database. 2024 [cited 2024 08.04.2024]."},{"issue":"1","key":"14842_CR18","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa1114248","volume":"367","author":"LA Inker","year":"2012","unstructured":"Inker, L. A. et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N. Engl. J. Med. 367(1), 20\u201329 (2012).","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"14842_CR19","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1515\/cclm.2011.733","volume":"50","author":"CG Fraser","year":"2012","unstructured":"Fraser, C. G. Reference change values. Clin. Chem. Lab. Med. 50(5), 807\u2013812 (2012).","journal-title":"Clin. Chem. Lab. Med."},{"issue":"5","key":"14842_CR20","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrneph.2011.31","volume":"7","author":"E Schwedhelm","year":"2011","unstructured":"Schwedhelm, E. & B\u00f6ger, R. H. The role of asymmetric and symmetric dimethylarginines in renal disease. Nat. Rev. Nephrol. 7(5), 275\u2013285 (2011).","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"14842_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1042\/bj1540179","volume":"154","author":"JR McDermott","year":"1976","unstructured":"McDermott, J. R. Studies on the catabolism of Ng-methylarginine, Ng, Ng-dimethylarginine and Ng, Ng-dimethylarginine in the rabbit. Biochem. J. 154(1), 179\u2013184 (1976).","journal-title":"Biochem. J."},{"issue":"3","key":"14842_CR22","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00726-005-0268-8","volume":"30","author":"M Busch","year":"2006","unstructured":"Busch, M. et al. Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease\u2014Possible candidates for paradoxical epidemiology?. Amino Acids 30(3), 225\u2013232 (2006).","journal-title":"Amino Acids"},{"key":"14842_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00392-017-1172-4","volume":"107","author":"IE Emrich","year":"2017","unstructured":"Emrich, I. E. et al. Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease. Clin. Res. Cardiol. 107, 201 (2017).","journal-title":"Clin. Res. Cardiol."},{"issue":"Suppl 12","key":"14842_CR24","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1097\/00005344-199204002-00018","volume":"20","author":"P Vallance","year":"1992","unstructured":"Vallance, P. et al. Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J. Cardiovasc. Pharmacol. 20(Suppl 12), S60\u2013S62 (1992).","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"2","key":"14842_CR25","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1681\/ASN.V132490","volume":"13","author":"C Zoccali","year":"2002","unstructured":"Zoccali, C. et al. Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease. J. Am. Soc. Nephrol. 13(2), 490\u2013496 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"14842_CR26","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1046\/j.1523-1755.2002.00437.x","volume":"62","author":"C Zoccali","year":"2002","unstructured":"Zoccali, C. et al. Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients. Kidney Int. 62(1), 339\u2013345 (2002).","journal-title":"Kidney Int."},{"issue":"6","key":"14842_CR27","doi-asserted-by":"publisher","first-page":"e001833","DOI":"10.1161\/JAHA.115.001833","volume":"4","author":"P Willeit","year":"2015","unstructured":"Willeit, P. et al. Asymmetric dimethylarginine and cardiovascular risk: Systematic review and meta-analysis of 22 prospective studies. J. Am. Heart Assoc. 4(6), e001833 (2015).","journal-title":"J. Am. Heart Assoc."},{"issue":"11","key":"14842_CR28","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1161\/ATVBAHA.114.304398","volume":"34","author":"D Atzler","year":"2014","unstructured":"Atzler, D. et al. Homoarginine and cardiovascular outcome in the population-based Dallas Heart Study. Arterioscler. Thromb. Vasc. Biol. 34(11), 2501\u20132507 (2014).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"10","key":"14842_CR29","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1161\/CIRCULATIONAHA.109.908988","volume":"122","author":"W Marz","year":"2010","unstructured":"Marz, W. et al. Homoarginine, cardiovascular risk, and mortality. Circulation 122(10), 967\u2013975 (2010).","journal-title":"Circulation"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14842-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14842-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14842-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T17:44:24Z","timestamp":1757439864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14842-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14842"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-14842-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"18 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30520"}}